Carcinogenesis Advance Access originally published online on January 3, 2008
Carcinogenesis 2008 29(2):418-426; doi:10.1093/carcin/bgm225
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A novel rasH2 mouse carcinogenesis model that is highly susceptible to 4-NQO-induced tongue and esophageal carcinogenesis is useful for preclinical chemoprevention studies
Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan
1 Department of Oncologic Pathology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan
* To whom correspondence should be addressed. Tel: +81 76 218 8116; Fax: +81 76 286 6926; Email: takutt{at}kanazawa-med.ac.jp
We investigated the susceptibility of 4-nitroquinoline 1-oxide (4-NQO)-induced tongue carcinogenesis in male CB6F1-Tg-rasH2 @Jcl mice (Tg mice). The Tg mice were administered 4-NQO (20 p.p.m. in drinking water) for 2, 4, 6 or 8 weeks, and thereafter they were untreated up to week 24. At week 24, a higher incidence (80%) of tongue neoplasm with dysplasia was noted in the mice that received 4-NQO for 8 weeks in comparison with the other groups (20% incidence for each) treated with 4-NQO for 2, 4 and 6 weeks. Esophageal tumors also developed in the Tg mice were 4-NQO. Immunohistochemical observation revealed that the EP receptors, especially EP1 and EP2, expressed in the tongue and esophageal lesions induced by 4-NQO, thus suggesting the involvement of prostaglandin (PG) E2 and EP1,2 receptors in the tongue and esophageal carcinogenesis. Using this animal model, we investigated the potential chemopreventive ability of pitavastatin (1, 5 and 10 p.p.m. in diet for 15 weeks), starting 1 week after the cessation of 4-NQO-exposure (20 p.p.m. in drinking water for 8 weeks). Dietary pitavastatin at 10 p.p.m. significantly reduced the incidence and multiplicity of the tongue, but not esophageal neoplasms by the modulation of prostaglandin E2 biosynthesis, EP1 and EP2 expression and proliferation. Our results thus suggest that a rasH2 mouse model of 4-NQO-induced tongue and esophageal carcinogenesis can be utilized for investigating the pathogenesis of cancer development in these tissues and may well prove to be useful for identifying candidate cancer chemopreventive agents for the upper digestive organs.
Abbreviations: COX, cyclooxygenase; PAP, squamous cell papilloma; PBS, phosphate buffer saline; PCNA, proliferative cell nuclear antigen; PG, prostaglandin; PGE2, prostaglandin E2; SCC, squamous cell carcinoma; 4-NQO, 4-nitroquinoline 1-oxide
Received August 1, 2007; revised September 27, 2007; accepted September 27, 2007.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Toyoda, T. Tsukamoto, S. Takasu, N. Hirano, H. Ban, L. Shi, T. Kumagai, T. Tanaka, and M. Tatematsu Pitavastatin Fails to Lower Serum Lipid Levels or Inhibit Gastric Carcinogenesis in Helicobacter pylori-Infected Rodent Models Cancer Prevention Research, August 1, 2009; 2(8): 751 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Vitale-Cross, R. Czerninski, P. Amornphimoltham, V. Patel, A. A. Molinolo, and J. S. Gutkind Chemical Carcinogenesis Models for Evaluating Molecular-Targeted Prevention and Treatment of Oral Cancer Cancer Prevention Research, May 1, 2009; 2(5): 419 - 422. [Full Text] [PDF]
|
|
|
|
|
|
R. Hasina, L. E. Martin, K. Kasza, C. L. Jones, A. Jalil, and M. W. Lingen ABT-510 Is an Effective Chemopreventive Agent in the Mouse 4-Nitroquinoline 1-Oxide Model of Oral Carcinogenesis Cancer Prevention Research, April 1, 2009; 2(4): 385 - 393. [Abstract] [Full Text] [PDF]
|
|